Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. [electronic resource]
Producer: 20080710Description: 108-15 p. digitalISSN:- 0165-5728
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies -- blood
- Cytokines -- metabolism
- Dose-Response Relationship, Drug
- Drug Evaluation
- Female
- Humans
- Immunosuppressive Agents -- pharmacology
- Leukocytes, Mononuclear -- drug effects
- Male
- Middle Aged
- Myasthenia Gravis -- drug therapy
- Prednisolone -- therapeutic use
- Receptors, Cholinergic -- immunology
- Retrospective Studies
- Severity of Illness Index
- Statistics, Nonparametric
- Tacrolimus -- adverse effects
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.